归翘栓治疗慢性盆腔炎临床研究  被引量:7

The Clinical Research of Guiqiao Rectal Suppository Treating Chronic Pelvic Inflammation

在线阅读下载全文

作  者:蔡玉华[1] 刘弘[2] 艾莉[1] 王燕[1] 顾丽贞[1] 王丽霞[1] 王彦云[1] 

机构地区:[1]中国中医研究院广安门医院,北京100053 [2]中日友好医院

出  处:《中国中医药信息杂志》2002年第11期8-10,共3页Chinese Journal of Information on Traditional Chinese Medicine

基  金:国家科技部2000年攻关课题(№.96-920-06-05-10)

摘  要:目的:观察中药新制剂归翘栓治疗慢性盆腔炎的确切疗效和其他作用。方法:将80例门诊慢性盆腔炎患者随机分为治疗组和对照组,每组40例。治疗组给予归翘栓,对照组给予康妇消炎栓。两组用药均为肛门栓剂,20d为一疗程,连用1~3个疗程。治疗前后采用评分法记录症状与体征改善的情况,并观察用药前后血、尿常规的变化。结果:归翘栓治疗慢性盆腔炎总显效率为77.5%,总有效率为97.5%,体征与症状均有明显改善,平均起效时间为11.28d,与对照组比较,差异显著(P<0.05)。结论:归翘栓适用于中重度慢性盆腔炎患者,尤其是属于气滞血瘀型的患者。Objective:To investigate the certain curative effect and other functions of Guiqiao Rectal Suppository treating chronic pelvic inflammation. Method:80 cases from our outpatient were divided into treating group with Guiqiao Rectal Suppository and control group with Kangfuxiaoyan Rectal Suppository. Each group included 40 patients who were administered the respective medicine 20 days for one course of treatment, continued 1~3 courses of treatment. The method of giving mark was taken to record the conditions of improving symptoms and signs before and after treatment and to observe variation of blood, urine and other routine in tests before and after administering medicine. Results:The whole remarkable effective rate of Guiqiao Rectal Suppository treating chronic pelvic inflammation is 77.5%, its whole effective rate is 97.5%, and its average effect-occurring time is 11.28 days, all quite better than the control group, there is an obvious difference (P<0.05 ). Conclusion:Guiqiao Rectal Suppository can be effectively applied to curing the patients with chronic pelvic inflammation of middle and serious degrees, especially the patients with syndrome of Qi stasis and blood stagnation.

关 键 词:归翘栓 治疗 慢性盆腔炎 临床研究 辨证分型 

分 类 号:R271.913.3[医药卫生—中西医结合] R[医药卫生—中医妇科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象